Table 2. Clinical characteristics of... | American Society of Hematology

Table 2.

Clinical characteristics of patients without DLI

Patient no.	Disease	Age, y, at BMT/sex	BMT conditioning regimen	Disease status at BMT	BM CD3⁺ cells per kilogram infused	Disease status after BMT	Acute GVH disease stage after BMT
10	MM	45/M	CTX/BUS	PR	0.25 × 10⁶	PD	0
11	MM	38/F	CTX/TBI	PR	0.47 × 10⁶	CR	0
12	MM	49/M	CTX/TBI	PR	0.97 × 10⁶	CR	2
13	MM	43/F	CTX/TBI	PR	0.06 × 10⁶	CR	3
14	NHL	34/M	CTX/TBI	CR	0.85 × 10⁶	PR	0
15	NHL	32/M	CTX/TBI	CR	0.43 × 10⁶	PR	0
16	MM	50/M	CTX/TBI	PR	1.60 × 10⁶	PR	0

Patient no.	Disease	Age, y, at BMT/sex	BMT conditioning regimen	Disease status at BMT	BM CD3⁺ cells per kilogram infused	Disease status after BMT	Acute GVH disease stage after BMT
10	MM	45/M	CTX/BUS	PR	0.25 × 10⁶	PD	0
11	MM	38/F	CTX/TBI	PR	0.47 × 10⁶	CR	0
12	MM	49/M	CTX/TBI	PR	0.97 × 10⁶	CR	2
13	MM	43/F	CTX/TBI	PR	0.06 × 10⁶	CR	3
14	NHL	34/M	CTX/TBI	CR	0.85 × 10⁶	PR	0
15	NHL	32/M	CTX/TBI	CR	0.43 × 10⁶	PR	0
16	MM	50/M	CTX/TBI	PR	1.60 × 10⁶	PR	0

MM indicates multiple myeloma; NHL, non-Hodgkin lymphoma; CTX, cyclophosphamide; BUS, busulfan; TBI, total body irradiation; PD, progressive disease; PR, partial response; and CR, complete response.

View Large

This Feature Is Available To Subscribers Only